Long-term cardiovascular outcomes in peritoneal dialysis patients: a systematic review

Authors

  • Hajira V. Kakkadapram Department of Critical Care, Iqraa International Hospital and Research Center, Calicut, Kerala, India
  • M. S. Huq Department Public Health, Deep Institute of Community Ophthalmology, Rangpur, Bangladesh

DOI:

https://doi.org/10.18203/2349-3933.ijam20251943

Keywords:

Peritoneal dialysis, Cardiovascular mortality, Risk factors, Long-term outcomes

Abstract

Peritoneal dialysis (PD) is a therapy for end-stage kidney disease that is increasingly used worldwide, especially in developing countries. Despite its benefits, PD patients remain at high risk for cardiovascular disease and related mortality due to unique metabolic and inflammatory risk factors. We performed a systematic review of cohort studies reporting cardiovascular and all-cause events in adult patients receiving PD. A search of PubMed, Embase, Scopus, and the Cochrane Library identified 716 studies; following after the screening and full-text review, 20 studies (7 prospective, 13 retrospective) were included. Data were extracted on study and participant characteristics, PD modality, outcomes, risk factors and methodological quality. All-cause mortality varied between 19.4 and 42.4% with CVD-related mortality representing 40–55% of all deaths. Vascular calcification (HR 8.01 for AAC >39%), hypoalbuminemia (HR 2.84), hypomagnesemia (HR 1.58), and inflammation (elevated neutrophil-to-lymphocyte ratio, HR 2.60; platelet-to-albumin ratio, HR 1.50) were significant modifiable risk factors for events. The incidence of peritonitis predicted cardiovascular death in a dose-response relationship. Cardiopathy (LV diastolic dysfunction, HR 2.25) and metabolism (remission of low triiodothyronine, HR 0.86 for each 10 ng/dl) were also independent predictors. Confounding and missing data yielded risk of bias as moderate or serious in most studies. Long-term cardiovascular outcomes in PD patients are driven by a complex interplay of vascular, inflammatory, metabolic, and cardiac factors. Addressing these modifiable risks should be prioritized in clinical management and research to improve survival in this high-risk population.

Metrics

Metrics Loading ...

References

Hashimoto K, Kamijo Y. Current progress in peritoneal dialysis: a narrative review of progress in peritoneal dialysis fluid. Life. 2025;15(2):279. DOI: https://doi.org/10.3390/life15020279

Elzorkany K, Alhamad MA, Albaqshi BM. Knowledge about peritoneal dialysis among patients with end-stage kidney disease on hemodialysis: a cross-sectional study. Ann Med. 2024;56(1):2411019. DOI: https://doi.org/10.1080/07853890.2024.2411019

François K, Bargman JM. Evaluating the benefits of home-based peritoneal dialysis. Int J Nephrol Renovasc Dis. 2014;7:447-55. DOI: https://doi.org/10.2147/IJNRD.S50527

Villa JD, Escobar KB, Escobar GL, Rodriguez CFE. WCN24-1639 automated peritoneal dialysis in patients with low peritoneal transport, experience in a single Mexican center. Kidney Int Reports. 2024;9(4):595. DOI: https://doi.org/10.1016/j.ekir.2024.02.1248

Malik S. Peritoneal Dialysis. In: Malik S, ed. Best of Five MCQs for the European Specialty Examination in Nephrology. 1st ed. Oxford University Press Oxford; 2023:167-80. DOI: https://doi.org/10.1093/oso/9780192844163.003.0010

Bello AK, Okpechi IG, Osman MA. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol. 2022;18(12):779-93. DOI: https://doi.org/10.1038/s41581-022-00623-7

Li PKT, Chow KM, Van De Luijtgaarden MWM. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90-103. DOI: https://doi.org/10.1038/nrneph.2016.181

Herzog CA. Cardiac arrest in dialysis patients: Approaches to alter an abysmal outcome. Kidney Int. 2003;63:197-200. DOI: https://doi.org/10.1046/j.1523-1755.63.s84.17.x

Echefu G, Stowe I, Burka S, Basu-Ray I, Kumbala D. Pathophysiological concepts and screening of cardiovascular disease in dialysis patients. Front Nephrol. 2023;3:1198560. DOI: https://doi.org/10.3389/fneph.2023.1198560

Jegatheesan D, Cho Y, Johnson DW. Clinical Studies of Interventions to Mitigate Cardiovascular Risk in Peritoneal Dialysis Patients. Sem Nephrol. 2018;38(3):277-90. DOI: https://doi.org/10.1016/j.semnephrol.2018.02.007

Peng J, Li A, Yin L, Yang Q, Pan J, Yi B. Estimated Glucose Disposal Rate Predicts Renal Progression in Type 2 Diabetes Mellitus: A Retrospective Cohort Study. J Endocrine Soc. 2023;7(7):69. DOI: https://doi.org/10.1210/jendso/bvad069

Roumeliotis S, Dounousi E, Salmas M, Eleftheriadis T, Liakopoulos V. Unfavourable effects of peritoneal dialysis solutions on the peritoneal membrane: the role of oxidative stress. Biomolecules. 2020;10(5):768. DOI: https://doi.org/10.3390/biom10050768

McIntyre CW. Hemodynamic Effects of Peritoneal Dialysis. Perit Dial Int. 2011;31(2):73-6. DOI: https://doi.org/10.3747/pdi.2010.00069

Shah S, Weinhandl E, Gupta N, Leonard AC, Christianson AL, Thakar CV. Cardiovascular outcomes in patients on home hemodialysis and peritoneal dialysis. Kidney360. 2024;5(2):205-15. DOI: https://doi.org/10.34067/KID.0000000000000360

Lozier MR, Sanchez AM, Lee JJ, Tamariz LJ, Valle GA. Comparison of Cardiovascular Outcomes by Dialysis Modality: A Systematic Review and Meta-Analysis. Perit Dial Int. 2019;39(4):306-14.

Hepburn KS, Lambert K, Mullan J, McAlister B, Lonergan M, Cheikh Hassan HI. Peritoneal dialysis‐related peritonitis as a risk factor for cardiovascular events. Internal Med J. 2021;51(3):404-10. DOI: https://doi.org/10.1111/imj.14769

Jain AK, Blake P, Cordy P, Garg AX. Global trends in rates of peritoneal dialysis. J American Soc Nephrol. 2012;23(3):533-44. DOI: https://doi.org/10.1681/ASN.2011060607

Yang B, Wang M, Tong X, Ankawi G, Sun L, Yang H. Experimental models in peritoneal dialysis (Review). Exp Ther Med. 2021;21(3);9671. DOI: https://doi.org/10.3892/etm.2021.9671

Page MJ, McKenzie JE, Bossuyt PM. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;3:71. DOI: https://doi.org/10.1136/bmj.n71

Higgins JPT, Morgan RL, Rooney AA. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Env Int. 2024;186:108602. DOI: https://doi.org/10.1016/j.envint.2024.108602

Tsai CH, Lin LY, Lin YH, Tsai IJ, Huang JW. Abdominal aorta calcification predicts cardiovascular but not non-cardiovascular outcome in patients receiving peritoneal dialysis: A prospective cohort study. Medicine. 2020;99(37):21730. DOI: https://doi.org/10.1097/MD.0000000000021730

Xue Y, Xu B, Su C, Han Q, Wang T, Tang W. Cardiorenal syndrome in incident peritoneal dialysis patients: What is its effect on patients’ outcomes. PLoS ONE. 2019;14(6):8082. DOI: https://doi.org/10.1371/journal.pone.0218082

Xia W, Yao X, Chen Y, Lin J, Vielhauer V, Hu H. Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients. BMC Nephrology. 2020;21(1):93. DOI: https://doi.org/10.1186/s12882-020-01993-5

Tsai C, Huang J, Lin C. Heart rhythm complexity predicts long‐term cardiovascular outcomes in peritoneal dialysis patients: a prospective cohort study. JAHA. 2020;9(2):3036. DOI: https://doi.org/10.1161/JAHA.119.013036

Querido S, Quadros Branco P, Silva Sousa H. Hypervolemia, hypoalbuminemia and mitral calcification as markers of cardiovascular risk in peritoneal dialysis patients. Revista Portuguesa de Cardiologia. 2017;36(9):599-604. DOI: https://doi.org/10.1016/j.repc.2016.12.014

Zhang F, Wu X, Wen Y. Hypomagnesemia Is a Risk Factor for Cardiovascular Disease- A nd Noncardiovascular Disease-Related Mortality in Peritoneal Dialysis Patients. Blood Purif. 2022;51(1):23-30. DOI: https://doi.org/10.1159/000514148

Hu PJ, Chen YW, Chen TT, Sung LC, Wu MY, Wu MS. Impact of dialysis modality on major adverse cardiovascular events and all-cause mortality: a national population-based study. Nephrology Dialysis Transplantation. 2021;36(5):901-8. DOI: https://doi.org/10.1093/ndt/gfaa282

Shen CH, Zheng CM, Kiu KT. Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan. Medicine. 2016;95(25):3933. DOI: https://doi.org/10.1097/MD.0000000000003933

Wu CK, Lee JK, Wu YF. Left ventricular diastolic dysfunction in peritoneal dialysis: a forgotten risk factor. Medicine. 2015;94(20):819. DOI: https://doi.org/10.1097/MD.0000000000000819

Chang TI, Nam JY, Shin SK, Kang EW. Low Triiodothyronine Syndrome and Long-Term Cardiovascular Outcome in Incident Peritoneal Dialysis Patients. Clin J Am Soc Nephrol. 2015;10(6):975-82. DOI: https://doi.org/10.2215/CJN.03350414

Wang J, Ma X, Si X, Wu M, Han W. Mean platelet volume and the association with all-cause mortality and cardiovascular mortality among incident peritoneal dialysis patients. BMC Cardiovasc Disord. 2023;23(1):3551. DOI: https://doi.org/10.1186/s12872-023-03551-x

Demir E, Çalışkan Y. Transplant immunology research centre of excellence, KOÇ university hospital, KOÇ university, Istanbul, Türkiye, outcome and risk factors for mortality in peritoneal dialysis patients: 22 Years of Experience in a Turkish Center. Turkish J Nephrol. 2024;33(2):223-8. DOI: https://doi.org/10.5152/turkjnephrol.2024.22491

Zhang L, Nie Y, Guo M. Neutrophil to Lymphocyte Ratio as a Predictor of Long-Term Outcome in Peritoneal Dialysis Patients: A 5-Year Cohort Study. Blood Purif. 2021;50(6):772-8. DOI: https://doi.org/10.1159/000510552

Pecoits-Filho R, Yabumoto FM, Campos LG. Peritonitis as a risk factor for long-term cardiovascular mortality in peritoneal dialysis patients: The case of a friendly fire. Nephrol. 2018;23(3):253-8. DOI: https://doi.org/10.1111/nep.12986

Ma H, Chen J, Zhan X. Platelet-to-albumin ratio: a potential biomarker for predicting all-cause and cardiovascular mortality in patients undergoing peritoneal dialysis. BMC Nephrol. 2024;25(1):8. DOI: https://doi.org/10.1186/s12882-024-03792-8

Hsieh YP, Chang CC, Kor CT. Relationship between uric acid and technique failure in patients on continuous ambulatory peritoneal dialysis: A long-term observational cohort study. BMJ Open. 2017;7(4):1138. DOI: https://doi.org/10.1136/bmjopen-2015-010816

Li J, Huang N, Zhong Z. Risk factors and outcomes of cardiovascular disease readmission within the first year after dialysis in peritoneal dialysis patients. Renal Failure. 2021;43(1):159-67. DOI: https://doi.org/10.1080/0886022X.2020.1866009

Xia X, Qiu Y, Yu J. Ten-year survival of patients treated with peritoneal dialysis: A prospective observational cohort study. Perit Dial Int. 2020;40(6):573-80. DOI: https://doi.org/10.1177/0896860820927534

Dai L, Yang Y, Liu L. The association of left ventricular fraction shortening with cardiovascular events in peritoneal dialysis patients. Renal Failure. 2023;45(2):1786. DOI: https://doi.org/10.1080/0886022X.2023.2261786

Xu LC, Zhou FF, Li M, et al. The correlation between low serum T3 levels and all-cause and cardiovascular mortality in peritoneal dialysis patients. Therap Clin Risk Man. 2021;17:851-61. DOI: https://doi.org/10.2147/TCRM.S324672

Lozier MR, Sanchez AM, Lee JJ, Tamariz LJ, Valle GA. Comparison of Cardiovascular Outcomes by Dialysis Modality: A Systematic Review and Meta-Analysis. Perit Dial Int. 2019;39(4):306-14. DOI: https://doi.org/10.3747/pdi.2018.00227

London GM. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transpl. 2003;18(9):1731-40. DOI: https://doi.org/10.1093/ndt/gfg414

Cooper BA, Penne EL, Bartlett LH, Pollock CA. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. American J Kid Dis. 2004;43(1):61-6. DOI: https://doi.org/10.1053/j.ajkd.2003.08.045

Stenvinkel P, Heimbürger O, Paultre F. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney International. 1999;55(5):1899-911. DOI: https://doi.org/10.1046/j.1523-1755.1999.00422.x

Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int. 2014;85(1):174-81. DOI: https://doi.org/10.1038/ki.2013.327

Faitatzidou D, Karagiannidis AG, Theodorakopoulou MP, Xanthopoulos A, Triposkiadis F, Sarafidis PA. Autonomic Nervous System Dysfunction in Peritoneal Dialysis Patients: An Underrecognized Cardiovascular Risk Factor. Am J Nephrol. 2024;55(1):37-55. DOI: https://doi.org/10.1159/000534318

Sahlawi MA, Wilson G, Stallard B, et al. Peritoneal dialysis-associated peritonitis outcomes reported in trials and observational studies: A systematic review. Perit Dial Int. 2020;40(2):132-40. DOI: https://doi.org/10.1177/0896860819893810

Jiang C, Zheng Q. Outcomes of peritoneal dialysis in elderly vs non-elderly patients: A systemic review and meta-analysis. PLoS ONE. 2022;17(2):263534. DOI: https://doi.org/10.1371/journal.pone.0263534

Assimon MM, Wenger JB, Wang L, Flythe JE. Ultrafiltration Rate and Mortality in Maintenance Hemodialysis Patients. American J Kidney Dis. 2016;68(6):911-22. DOI: https://doi.org/10.1053/j.ajkd.2016.06.020

Downloads

Published

2025-06-26

How to Cite

Kakkadapram, H. V., & Huq, M. S. (2025). Long-term cardiovascular outcomes in peritoneal dialysis patients: a systematic review. International Journal of Advances in Medicine, 12(4), 434–446. https://doi.org/10.18203/2349-3933.ijam20251943

Issue

Section

Systematic Reviews